Halozyme falls 6% after hours despite earnings and revenue beats and raised guidance
FROM THE WIRE · FINANCE.YAHOO.COM
Investing.com -- Halozyme Therapeutics Inc (NASDAQ:HALO) reported third-quarter results that exceeded Wall Street expectations, but shares tumbled 6% in after-hours trading Thursday as the company's raised full-year guidance met elevated investor expectations. Still guessing…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishThe stock falls because the raised guidance did not meet already elevated expectations.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Halozyme reported adjusted EPS of $2.39, versus a consensus of $2.28.
- 02Revenue rose 39% year-on-year to $493 million, above estimates.
- 03Royalty revenue grew 44% to $341 million, while the shares fell 6% after hours.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets